Market Research Logo

Global Axial Spondyloarthritis Treatment Market 2018-2022

Global Axial Spondyloarthritis Treatment Market 2018-2022

About Axial Spondyloarthritis Treatment

Axial spondyloarthritis treatment market covers the drugs used for the treatment of inflammatory rheumatic disease, which predominantly affects the spine and sacroiliac joints.

Technavio’s analysts forecast the Global Axial Spondyloarthritis Treatment Market to grow at a CAGR of 7.37% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the axial spondyloarthritis treatment market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of axial spondyloarthritis across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, axial spondyloarthritis treatment market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Pfizer
  • UCB
Market driver
  • Increase in the number of approved biosimilars
  • For a full, detailed list, view our report
Market challenge
  • High cost of biologics
  • For a full, detailed list, view our report
Market trend
  • Increase in the number of small molecules in the drug development pipeline
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Axial Spondyloarthritis Treatment Market 2018-2022

Technavio recognizes the following companies as the key players in the global axial spondyloarthritis treatment market: AbbVie, Amgen, Johnson & Johnson, Pfizer, and UCB.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the increase in the number of small molecules in the drug development pipeline. Small molecules are generally less expensive than biologics and they are expected to gain traction during the forecast period.”

According to the report, one driver influencing this market is the increase in the number of approved biosimilars that is widening the patient base. Considering the high cost of biologics, biosimilars appear as a cost-effective solution and the rise in the number of approved biosimilars will fuel the growth of the global axial spondyloarthritis market during the period of forecast.

Further, the report states that one challenge affecting this market is the high cost of biologics. Biologics are expensive due to some critical factors such as the high research and development costs and the lengthy testing and manufacturing process which is hindering the growth of the market.

Companies Mentioned

AbbVie
Amgen
Johnson & Johnson
Pfizer
UCB

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global axial spondyloarthritis treatment market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global axial spondyloarthritis treatment market – Market size and forecast 2017-2022 ($ mn)
      • Table Global axial spondyloarthritis treatment market – Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Pipeline landscape
    • Table Pipeline landscape by development phase 2018
    • Table Key clinical trial candidates of axial spondyloarthritis 2017-2018
  • Market segmentation by category
    • Segmentation by category
      • Table Global axial spondyloarthritis treatment market by category– Market share 2017-2022 (%)
    • Comparison by category
      • Table Comparison by category
    • Global ankylosing spondylitis treatment market – Market size and forecast 2017-2022
      • Table Global ankylosing spondylitis treatment market – Market size and forecast 2017-2022 ($ mn)
      • Table Global ankylosing spondylitis treatment market – Year-over-year growth 2018-2022 (%)
    • Global non-radiographic axial spondyloarthritis treatment market – Market size and forecast 2017-2022
      • Table Global non-radiographic axial spondyloarthritis treatment market – Market size and forecast 2017-2022 ($ mn)
      • Table Global non-radiographic axial spondyloarthritis treatment market – Year-over-year growth 2018-2022 (%)
    • Market opportunity by category
      • Table Market opportunity by category
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global axial spondyloarthritis treatment market by geography – Market share 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas – Market size and forecast 2017-2022
      • Table Americas – Market size and forecast 2017-2022 ($ mn)
      • Table Americas – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in the Americas
    • EMEA – Market size and forecast 2017-2022
      • Table EMEA – Market size and forecast 2017-2022 ($ mn)
      • Table EMEA – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC – Market size and forecast 2017-2022
      • Table APAC – Market size and forecast 2017-2022 ($ mn)
      • Table APAC – Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie
      • Table AbbVie: Overview
      • Table AbbVie – Business segments
      • Table AbbVie – Organizational developments
      • Table AbbVie – Geographic focus
      • Table AbbVie – Key offerings
      • Table AbbVie – Key customers
    • Amgen
      • Table Amgen: Overview
      • Table Amgen – Business segments
      • Table Amgen – Organizational developments
      • Table Amgen – Geographic focus
      • Table Amgen – Key offerings
      • Table Amgen – Key customers
    • Johnson & Johnson
      • Table Johnson & Johnson: Overview
      • Table Johnson & Johnson– Business segments
      • Table Johnson & Johnson– Organizational developments
      • Table Johnson & Johnson– Geographic focus
      • Table Johnson & Johnson– Segment focus
      • Table Johnson & Johnson– Key offerings
      • Table Johnson & Johnson– Key customers
    • Pfizer
      • Table Pfizer: Overview
      • Table Pfizer – Business segments
      • Table Pfizer – Organizational developments
      • Table Pfizer – Geographic focus
      • Table Pfizer– Segment focus
      • Table Pfizer – Key offerings
      • Table Pfizer – Key customers
    • UCB
      • Table UCB: Overview
      • Table UCB – Business segments
      • Table UCB – Organizational developments
      • Table UCB – Geographic focus
      • Table UCB – Key offerings
      • Table UCB – Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report